Literature DB >> 8212562

The NS 3 nonstructural protein of flaviviruses contains an RNA triphosphatase activity.

G Wengler1, G Wengler1.   

Abstract

The genome of flaviviruses consists of an infectious single-stranded RNA molecule which contains a type 1 cap structure at the 5'-terminus. The cap is synthesized by RNA triphosphatase, guanylyltransferase and methyltransferase. Since flaviviruses replicate in the cytoplasm, it can be assumed that these functions are performed by virus-coded proteins. We previously showed that subtilisin treatment of membranes isolated from cells infected with the West Nile flavivirus results in release of a 50 kDa molecular weight fragment of the viral nonstructural protein NS 3. This so-called p50-S protein contains the residue gly (168) of NS 3 at the amino-terminus and represents an RNA-stimulated NTPase. In the present report we present experimental evidence which indicates that the p50-S protein also contains the active site of an RNA triphosphatase. The activity specifically cleaves the beta,gamma-triphosphate bond at the 5'-terminus of RNA. The localization of NS 3 protein sequence elements with known functions indicates that this multifunctional protein contains a protease in the amino-terminal part, a helicase in the central region and the RNA triphosphatase in the carboxy-terminal domain. An amino acid sequence element which may be involved in recognition of the 5'-terminal RNA triphosphate is tentatively identified. A homologous element may be present in the vaccinia virus-coded RNA triphosphatase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212562     DOI: 10.1006/viro.1993.1587

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  78 in total

1.  cis- and trans-acting elements in flavivirus RNA replication.

Authors:  A A Khromykh; P L Sedlak; E G Westaway
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis.

Authors:  Grigori G Prikhod'ko; Elena A Prikhod'ko; Alexander G Pletnev; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Inhibition of dengue virus RNA synthesis by an adenosine nucleoside.

Authors:  Yen-Liang Chen; Zheng Yin; Jeyaraj Duraiswamy; Wouter Schul; Chin Chin Lim; Boping Liu; Hao Ying Xu; Min Qing; Andy Yip; Gang Wang; Wai Ling Chan; Hui Pen Tan; Melissa Lo; Sarah Liung; Ravinder Reddy Kondreddi; Ranga Rao; Helen Gu; Handan He; Thomas H Keller; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

5.  Characterization of dengue virus resistance to brequinar in cell culture.

Authors:  Min Qing; Gang Zou; Qing-Yin Wang; Hao Ying Xu; Hongping Dong; Zhiming Yuan; Pei-Yong Shi
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

6.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

7.  Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.

Authors:  S Butrapet; C Y Huang; D J Pierro; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Structure-based mutational analysis of the NS3 helicase from dengue virus.

Authors:  Aruna Sampath; Ting Xu; Alex Chao; Dahai Luo; Julien Lescar; Subhash G Vasudevan
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 10.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.